On October 1, 2021, Pharmaceutical company “Merck and Ridgeback Biotherapeutics” announced the early results of Phase-3 trials of its anti-viral drug called molnupiravir. As per the results, Molnupiravir...
The Health Minister of Goa recently recommended the use of “Ivermectin” to all people above the age of eighteen years. However, the World Health Organisation has warned against...
The Russian Authorities have approved a new COVID-19 vaccine called “EpicVacCorona”. It is a two shot vaccine. Key Highlights EpiVacCorona is a peptide-based vaccine. Sputnik V was the...
The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has...
The Food and Drug Administration (FDA) of America has authorized the use of blood plasma from the COVID-19 survivors. It will be used to treat the disease. As...
On July 11, 2020, the Dugs Controller General of India (DCGI) granted restricted emergency use of Itolizumab for moderate to severe COVI-19 patients. Highlights Itolizumab is a monoclonal...
The Drug Controller General of India approved to begin vaccine trial of Zydus Cadila. The firm is to conduct the vaccine trials in two phases. This is the...
On July 2, 2020, the Union Minister of Health and Family Welfare Dr Harsh Vardhan and Union Minister of HRD Ramesh Pokhriyal launched “Drug Discovery Hackathon”, 2020. Highlights...
